These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 18388801)

  • 1. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells in spontaneous autoimmune diseases of the central nervous system.
    Berer K; Wekerle H; Krishnamoorthy G
    Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells and antibodies in MS.
    Reindl M; Kuenz B; Berger T
    Results Probl Cell Differ; 2010; 51():99-113. PubMed ID: 19513636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).
    Ziemssen T; Ziemssen F
    Autoimmun Rev; 2005 Sep; 4(7):460-7. PubMed ID: 16137612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
    Ichikawa M; Johns TG; Liu J; Bernard CC
    J Immunol; 1996 Jul; 157(2):919-26. PubMed ID: 8752946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells and multiple sclerosis.
    Franciotta D; Salvetti M; Lolli F; Serafini B; Aloisi F
    Lancet Neurol; 2008 Sep; 7(9):852-8. PubMed ID: 18703007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell-targeted treatment for multiple sclerosis: mechanism of action and clinical data.
    Hawker K
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S19-25. PubMed ID: 18388796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
    Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in the immunopathogenesis of multiple sclerosis.
    Hemmer B; Archelos JJ; Hartung HP
    Nat Rev Neurosci; 2002 Apr; 3(4):291-301. PubMed ID: 11967559
    [No Abstract]   [Full Text] [Related]  

  • 15. Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Cross AH; Stark JL
    Immunol Res; 2005; 32(1-3):85-97. PubMed ID: 16106061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.
    Stefferl A; Brehm U; Storch M; Lambracht-Washington D; Bourquin C; Wonigeit K; Lassmann H; Linington C
    J Immunol; 1999 Jul; 163(1):40-9. PubMed ID: 10384097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS: a localized immune disease of the central nervous system.
    Calder V; Owen S; Watson C; Feldmann M; Davison A
    Immunol Today; 1989 Mar; 10(3):99-103. PubMed ID: 2472812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses.
    Huntington ND; Tomioka R; Clavarino C; Chow AM; Liñares D; Maña P; Rossjohn J; Cachero TG; Qian F; Kalled SL; Bernard CC; Reid HH
    Int Immunol; 2006 Oct; 18(10):1473-85. PubMed ID: 16914508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B- and T-cell responses in multiple sclerosis: novel approaches offer new insights.
    Hohlfeld R; Meinl E; Dornmair K
    J Neurol Sci; 2008 Nov; 274(1-2):5-8. PubMed ID: 18707694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.